Laura Calder

Laura Calder, as Chief Growth Officer at Nira Medical, plays a pivotal role in shaping the company's strategic expansion and innovative approach to neurological and rheumatic care delivery. Leveraging her extensive experience in building high-performing teams that seamlessly integrate technology and product development, Laura is focused on driving scalable growth through data-driven decision-making and operational excellence. Her expertise in strategic finance, operations, and planning—honed during her tenure at Uber—enables her to navigate complex healthcare landscapes and identify opportunities for disruptive innovation within the patient-centric model Nira Medical champions.

In her current role, Laura spearheads initiatives to enhance patient access to groundbreaking treatments for conditions such as Alzheimer’s, MS, and Parkinson’s by leveraging advanced data analysis, statistical modeling, and digital health solutions. Her proficiency with tools like PowerPoint, Microsoft Excel, and statistical software such as Stata, SAS, and Matlab allows her to translate complex clinical and operational data into actionable insights that inform product development and market strategy. Laura’s passion for operationalizing complex problems is evident in her leadership of key projects aimed at integrating cutting-edge technology into clinical workflows, optimizing patient engagement, and expanding Nira Medical’s reach through strategic partnerships and innovative care models.

Her ability to bridge the gap between technological innovation and real-world healthcare delivery positions her as a driving force behind Nira Medical’s mission to revolutionize neurological and rheumatic care. With a focus on building collaborative, high-performing teams, Laura continues to foster a culture of innovation, agility, and patient-centered care that aligns with the company’s vision of transforming treatment access and outcomes for millions suffering from chronic neurological conditions.